Bioanalytical Systems, Inc. (NASDAQ:BASI)
About the company
Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
|Name||Ticker||Market capitalization (in USD Million)||Revenues (in USD Million)||Price/Book||Price/Earning||Net margin (in %)|
|IQVIA Holdings, Inc.||IQV||28708.02||11158.00||5.00||133.02||1.93|
|Laboratory Corp. of America Holdings||LH||16922.64||11587.00||2.39||53.63||2.77|
|Quest Diagnostics, Inc.||DGX||15887.52||7726.00||2.76||18.60||10.33|
|Syneos Health, Inc.||SYNH||5976.28||4720.00||1.97||30.31||4.13|
|National Research Corp.||NRC||1466.40||130.00||38.11||40.29||27.51|
|Apollo Medical Holdings, Inc.||AMEH||577.44||625.00||2.90||32.08||2.89|
|Bioanalytical Systems, Inc.||BASI||54.56||55.00||5.45||-23.62||-3.94|
|Protalix Biotherapeutics, Inc.||PLX||52.35||66.00||-3.67||-5.54||-14.18|
|Interpace Biosciences, Inc.||IDXG||20.68||27.00||3.06||-0.60||-121.14|
|Pressure BioSciences, Inc.||PBIO||4.50||2.00||-0.52||-0.28||-876.69|
Latest insider transactions
|Date||Role||Name||Transaction||Quantity||Quantity Owned After|
WEST LAFAYETTE — Fourteen months ago, Bioanalytical Systems Inc. made a splash when it appointed a new chief operating officer to oversee operations at its three sites in Indiana and Missouri. The ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Before it's here, it's on the Bloomberg Terminal.
DNA and others in biological systems. Various scientific processes depend on precise quantification of drugs and other endogenous substances in the biological samples. The bioanalytical testing ...
POE Immunoassay: Plate-based oligonucleotide electro-chemiluminescent immunoassay for the quantification of nucleic acids in biological matrices
Oligonucleotide therapeutics use short interfering RNA (siRNA) or antisense oligonucleotide (ASO) molecules to exploit endogenous systems ... is challenging. Bioanalytical assays are important ...
The dividend yield measures the ratio of dividends paid / net income. Companies with a higher dividend yield tend to have a business model that allows them to pay out more dividends from net income ...
Insider Buying: The Bioanalytical Systems, Inc. (NASDAQ:BASI) CFO & VP of Finance Just Bought US$59k Worth Of Shares
Even if it's not a huge purchase, we think it was good to see that Beth Taylor, the CFO & VP of Finance of Bioanalytical Systems, Inc. (NASDAQ:BASI) recently shelled out US$59k to buy stock ...